Skip to main content
. 2023 Apr 5;146(9):3898–3912. doi: 10.1093/brain/awad118

Table 2.

Patient demographics by outcome

Feature Total Good outcome Engel I Poor outcome Engel II–IV P
Patients, n 43 25 18
Male/female, n 22/21 13/12 9/9 1a
Age at surgery, years 12 (7.3–15.8) 11 (6.8–15) 13 (9–16) 0.27b
Age at epilepsy onset, years 4 (1.4–7) 4 (1.3–7.3) 4 (1.5–7) 0.76b
Epilepsy side L 15/12 8/8 7/4 0.91a
R 4/4 3/2 1/3
Gen 3/5 2/2 1/2
Pathology NL 5/6 1/4 4/2 0.56a
MCD 13/13 10/7 3/6
ACQ 4/2 2/1 2/1
iEEG type ECoG 11/6 5/4 6/2 0.86a
sEEG 3/8 2/5 1/3
Both 8/7 6/3 2/4
iEEG, n ECoG 96 (86–120) 88 (78–100) 120 (92–132) 0.02b
sEEG 162 (112–189) 162 (93–188) 158 (145–189)
Both 112 (101–124) 102(94–124) 122 (112–154)
Resection volume, cm3 22.7 (11.1–43.8) 25.2 (14.9–47.2) 11.2 (6.7–25.2) 0.03b
Resection percentage of total brain volume, % 2.3 (1.1–3.8) 2.6 (1.8–4.4) 1.2 (0.7–2.9) 0.04b
SOZ channels, n 9 (5–20) 10 (6.75–20) 7 (5–22) 0.42b
T lobe/extra T 9/34 6/19 3/15 0.71a
Follow-up, years 4 (2–5.8) 4 (2–6) 3.5 (2–5) 0.53b

ACQ = acquired (i.e. stroke, neoplasm or trauma); Gen = generalized; iEEG = intracranial EEG; L = left; MCD = malformation of cortical development (i.e. focal cortical dysplasia, polymicrogyria or tuberous sclerosis complex); NL = non-lesional; R = right; T = temporal.

Fisher's exact test.

Wilcoxon rank sum test.